Literature DB >> 24506884

The two active X chromosomes in female ESCs block exit from the pluripotent state by modulating the ESC signaling network.

Edda G Schulz1, Johannes Meisig2, Tomonori Nakamura3, Ikuhiro Okamoto3, Anja Sieber2, Christel Picard4, Maud Borensztein4, Mitinori Saitou5, Nils Blüthgen2, Edith Heard6.   

Abstract

During early development of female mouse embryos, both X chromosomes are transiently active. X gene dosage is then equalized between the sexes through the process of X chromosome inactivation (XCI). Whether the double dose of X-linked genes in females compared with males leads to sex-specific developmental differences has remained unclear. Using embryonic stem cells with distinct sex chromosome compositions as a model system, we show that two X chromosomes stabilize the naive pluripotent state by inhibiting MAPK and Gsk3 signaling and stimulating the Akt pathway. Since MAPK signaling is required to exit the pluripotent state, differentiation is paused in female cells as long as both X chromosomes are active. By preventing XCI or triggering it precociously, we demonstrate that this differentiation block is released once XX cells have undergone X inactivation. We propose that double X dosage interferes with differentiation, thus ensuring a tight coupling between X chromosome dosage compensation and development.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24506884     DOI: 10.1016/j.stem.2013.11.022

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  66 in total

1.  Structural organization of the inactive X chromosome in the mouse.

Authors:  Luca Giorgetti; Bryan R Lajoie; Ava C Carter; Mikael Attia; Ye Zhan; Jin Xu; Chong Jian Chen; Noam Kaplan; Howard Y Chang; Edith Heard; Job Dekker
Journal:  Nature       Date:  2016-07-18       Impact factor: 49.962

2.  Derivation of ground-state female ES cells maintaining gamete-derived DNA methylation.

Authors:  Masaki Yagi; Satoshi Kishigami; Akito Tanaka; Katsunori Semi; Eiji Mizutani; Sayaka Wakayama; Teruhiko Wakayama; Takuya Yamamoto; Yasuhiro Yamada
Journal:  Nature       Date:  2017-07-26       Impact factor: 49.962

3.  Stem cells: The cost of perpetual youth.

Authors:  Thomas P Zwaka
Journal:  Nature       Date:  2017-07-26       Impact factor: 49.962

4.  DUSP9 Modulates DNA Hypomethylation in Female Mouse Pluripotent Stem Cells.

Authors:  Jiho Choi; Kendell Clement; Aaron J Huebner; Jamie Webster; Christopher M Rose; Justin Brumbaugh; Ryan M Walsh; Soohyun Lee; Andrej Savol; Jean-Pierre Etchegaray; Hongcang Gu; Patrick Boyle; Ulrich Elling; Raul Mostoslavsky; Ruslan Sadreyev; Peter J Park; Steven P Gygi; Alexander Meissner; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2017-03-30       Impact factor: 24.633

Review 5.  Trans-spliced long non-coding RNA: an emerging regulator of pluripotency.

Authors:  Chun-Ying Yu; Ching-Yu Chuang; Hung-Chih Kuo
Journal:  Cell Mol Life Sci       Date:  2018-06-30       Impact factor: 9.261

6.  Getting off the ground state: X chromosome inactivation knocks down barriers to differentiation.

Authors:  Robert Morey; Louise C Laurent
Journal:  Cell Stem Cell       Date:  2014-02-06       Impact factor: 24.633

7.  Coupling of X-chromosome reactivation with the pluripotent stem cell state.

Authors:  Bernhard Payer; Jeannie T Lee
Journal:  RNA Biol       Date:  2014-08-19       Impact factor: 4.652

8.  Pluripotent cells will not dosage compensate.

Authors:  Jianhao Jiang; Alyssa C Lau; Györgyi Csankovszki
Journal:  Worm       Date:  2014-05-08

Review 9.  X-chromosome dosage as a modulator of pluripotency, signalling and differentiation?

Authors:  Edda G Schulz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-11-05       Impact factor: 6.237

Review 10.  Mechanistic insights in X-chromosome inactivation.

Authors:  Zhipeng Lu; Ava C Carter; Howard Y Chang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-11-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.